HK1098372A1 - Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein - Google Patents

Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein

Info

Publication number
HK1098372A1
HK1098372A1 HK07104918.4A HK07104918A HK1098372A1 HK 1098372 A1 HK1098372 A1 HK 1098372A1 HK 07104918 A HK07104918 A HK 07104918A HK 1098372 A1 HK1098372 A1 HK 1098372A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor
pharmaceutical composition
fusion protein
benzodiazepine derivative
rsv fusion
Prior art date
Application number
HK07104918.4A
Other languages
English (en)
Inventor
Kenneth Powell
Richard Kelsey
Malcolm Carter
Dagmar Alber
Lara Wilson
Elisa Henderson
Phil Chambers
Debra Taylor
Stan Tyms
Verity Dowdell
Original Assignee
Arrow Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow Therapeutics Ltd filed Critical Arrow Therapeutics Ltd
Publication of HK1098372A1 publication Critical patent/HK1098372A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK07104918.4A 2004-03-19 2007-05-08 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein HK1098372A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0406282.4A GB0406282D0 (en) 2004-03-19 2004-03-19 Therapeutic compounds
PCT/GB2005/001018 WO2005089769A1 (fr) 2004-03-19 2005-03-18 Composition pharmaceutique comprenant un derive de benzodiazepine et un inhibiteur de la proteine de fusion du vrs

Publications (1)

Publication Number Publication Date
HK1098372A1 true HK1098372A1 (en) 2007-07-20

Family

ID=32118068

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104918.4A HK1098372A1 (en) 2004-03-19 2007-05-08 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein

Country Status (19)

Country Link
US (1) US8853204B2 (fr)
EP (1) EP1727550B1 (fr)
JP (1) JP4940128B2 (fr)
KR (2) KR101292431B1 (fr)
CN (1) CN1933842A (fr)
AT (1) ATE437643T1 (fr)
AU (2) AU2005224157B2 (fr)
BR (1) BRPI0507654A (fr)
CA (1) CA2558112C (fr)
CY (1) CY1109523T1 (fr)
DE (1) DE602005015686D1 (fr)
DK (1) DK1727550T3 (fr)
ES (1) ES2327757T3 (fr)
GB (1) GB0406282D0 (fr)
HK (1) HK1098372A1 (fr)
PL (1) PL1727550T3 (fr)
PT (1) PT1727550E (fr)
RU (1) RU2388476C2 (fr)
WO (1) WO2005089769A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
MX2009005368A (es) * 2006-11-21 2009-06-05 Novartis Ag Formulacion parenteral estable que contiene un inhibidor de rsv de una estructura de benzodiazepina.
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
HUE060259T2 (hu) 2015-07-22 2023-02-28 Enanta Pharm Inc Benzodiazepin származékok mint RSV-gátlók
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
GB201613942D0 (en) 2016-08-15 2016-09-28 Univ Of Durham The An antimicrobial compound
WO2018129287A1 (fr) 2017-01-06 2018-07-12 Enanta Pharmaceuticals, Inc. Dérivés d'hétéroaryldiazépine utilisés comme inhibiteurs du vrs
CA3065368A1 (fr) 2017-02-16 2018-08-23 Enanta Pharmaceuticals, Inc. Procedes pour la preparation de derives de benzodiazepine
US10752598B2 (en) 2017-06-07 2020-08-25 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as RSV inhibitors
US10851115B2 (en) 2017-06-30 2020-12-01 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
BR112020006334A2 (pt) * 2017-09-29 2020-09-24 Enanta Pharmaceuticals, Inc. combinação de agentes farmacêuticos como inibidores de rsv
WO2019094903A1 (fr) * 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Procédé pour la résolution de dérivés benzodiazépin-2-one et benzoazépin-2-one
WO2019094920A1 (fr) * 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Dérivés d'azépin-2-one en tant qu'inhibiteurs du vrs
US10975094B2 (en) 2018-04-11 2021-04-13 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
KR20210138684A (ko) 2019-03-18 2021-11-19 이난타 파마슈티칼스, 인코포레이티드 Rsv 억제제로서의 벤조디아제핀 유도체
US11179400B2 (en) 2019-04-09 2021-11-23 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
AU2020357452A1 (en) 2019-10-04 2022-05-12 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
GB201915273D0 (en) * 2019-10-22 2019-12-04 Reviral Ltd Pharmaceutical compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
WO2022086840A1 (fr) 2020-10-19 2022-04-28 Enanta Pharmaceuticals, Inc. Composés hétérocycliques en tant qu'agents antiviraux
BR112023016970A2 (pt) 2021-02-26 2023-10-10 Enanta Pharm Inc Compostos heterocíclicos antivirais
US12080039B2 (en) 2021-06-08 2024-09-03 Kyndryl, Inc. Contextual policy-based computer vision control

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
EP0491218A1 (fr) * 1990-12-17 1992-06-24 F. Hoffmann-La Roche Ag Benzodiazépinones
EP1019382A1 (fr) * 1997-04-07 2000-07-19 Axys Pharmaceuticals, Inc. Composes et compositions pour traitement de maladies associees a une serine protease, en particulier une activite de tryptase
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) * 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US6737428B2 (en) * 2001-12-10 2004-05-18 Bristol-Myers Squibb Company BIS hydrochloride monohydrate salt of RSV fusion inhibitor
JP2004107494A (ja) * 2002-09-18 2004-04-08 National Institute For Materials Science 熱可塑性層状アルキルシロキサンとその製造方法
US7582624B2 (en) * 2002-09-20 2009-09-01 Arrow Therapeutics Limited Benzodiazepine derivatives and pharmaceutical compositions containing them
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds

Also Published As

Publication number Publication date
KR101292431B1 (ko) 2013-07-31
EP1727550A1 (fr) 2006-12-06
PL1727550T3 (pl) 2010-01-29
ES2327757T3 (es) 2009-11-03
PT1727550E (pt) 2009-08-28
ATE437643T1 (de) 2009-08-15
AU2005224157A1 (en) 2005-09-29
AU2005224157B2 (en) 2009-05-28
US20070142403A1 (en) 2007-06-21
WO2005089769A1 (fr) 2005-09-29
CY1109523T1 (el) 2014-08-13
CN1933842A (zh) 2007-03-21
JP2007529489A (ja) 2007-10-25
CA2558112C (fr) 2014-07-29
DE602005015686D1 (de) 2009-09-10
KR20070009629A (ko) 2007-01-18
BRPI0507654A (pt) 2007-07-10
CA2558112A1 (fr) 2005-09-29
DK1727550T3 (da) 2009-10-19
EP1727550B1 (fr) 2009-07-29
KR20130042593A (ko) 2013-04-26
US8853204B2 (en) 2014-10-07
AU2009212826A1 (en) 2009-09-17
RU2388476C2 (ru) 2010-05-10
GB0406282D0 (en) 2004-04-21
JP4940128B2 (ja) 2012-05-30
RU2006136880A (ru) 2008-04-27

Similar Documents

Publication Publication Date Title
PL1727551T3 (pl) Kompozycja farmaceutyczna zawierająca pochodną benzodiazepiny i inhibitor fuzji białek RSV
HK1098372A1 (en) Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
AU2003264038A1 (en) Combination pharmaceutical agents as inhibitors of hcv replication
WO2007139856A3 (fr) Inhibiteurs de métalloprotéases hétérobicycliques
MXPA05002871A (es) Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen.
WO2002044183A3 (fr) Composes et leurs utilisations
UA89220C2 (ru) Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
AU2003213020A1 (en) Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HK1049330A1 (en) Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
CA2504735A1 (fr) Derives de phenylalanine utilises comme inhibiteurs de la dipeptidyl peptidase dans le traitement ou la prevention du diabete
WO2004050022A8 (fr) Derives de phenylalanine utilises comme inhibiteurs de la dipeptidylpeptisase pour le traitement ou la prevention de diabetes
AU2002338806A1 (en) Pharmaceutical combinations of pde-v inhibitors and other agents
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
AU2001230395A1 (en) Use of cox-2 inhibitors as gastroprokinetics
WO2004052236A3 (fr) Methodes et compositions de traitement de l'otite moyenne
AU2003201071A1 (en) Stable pharmaceutical compositions comprising ace inhibitor(s)
WO2001056555A3 (fr) Utilisation d'inhibiteurs de cox-2 dans le traitement de la constipation
WO2004016741A3 (fr) Inhibiteurs de la prenylation contenant du dimethylcyclobutane, leurs methodes de synthese et leur utilisation
GB0308201D0 (en) Novel compounds
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2003227186A1 (en) Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150318